Sign up United Kingdom
Auris Medical (NASDAQ:EARS)

Auris Medical (NASDAQ:EARS)

Share Price
$ 0.96
0.11 (12.94 %)
Market Cap
$23.10 m
Proactive Investors - Run By Investors For Investors

Auris Medical

Auris Medical is the leading pioneer in the emerging field of therapies for neurotologic disorders affecting the inner ear.

It has two projects in advanced clinical development, Keyzilen® for the treatment of acute inner ear tinnitus and AM-111 for the treatment of acute inner ear hearing loss.

In addition, it has AM-125 in early clinical development for the treatment of...

52-week High/Low: $9.50 / $0.23
Sector: MSN - Healthcare & pharmaceuticals
Market Cap: $23.10M

Auris Medical

Interactive graph

col 3
col 4
col 5
col 6

Auris Medical Timeline

© Proactive Investors 2018

Proactive Investors Limited, trading as “Proactiveinvestors United Kingdom”, is Authorised and regulated by the Financial Conduct Authority.
Registered in England with Company Registration number 05639690. Group VAT registration number 872070825 FCA Registration number 559082. You can contact us here.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use